Talanta 1997-01-01

Mixed-ligand chelate extraction of trivalent lanthanides with 4,4,4-trifluoro-1-phenyl-1,3-butanedione and neutral oxo-donors.

M L Reddy, S Sujatha, R L Varma, T R Ramamohan, T P Rao, C S Iyer, A D Damodaran

Index: Talanta 44(1) , 97-103, (1997)

Full Text: HTML

Abstract

Mixed-ligand chelate extraction of trivalent lanthanides such as Nd(III), Eu(III) and Lu(III) into benzene with mixtures of 4,4,4-trifluoro-1-phenyl-1,3-butanedione (HBFA) and bis-2-ethylhexyl sulphoxide (B2EHSO) or triphenylphosphine oxide (TPhPO) from thiocyanate solutions was investigated. The results demonstrate that these metal ions are extracted as Ln(BFA)(3) with HBFA alone and in the presence of a neutral oxo-donor, B2EHSO or TPhPO(S), as Ln(BFA)(3).S and Ln(BFA)(3).2S. The equilibrium constants of the above species increase monotonically with decreasing ionic radii of these metals ions. The addition of a neutral donor to the metal chelate system not only enhances the extraction efficiency but also improves the selectivity among these trivalent lanthanides. Hence this mixed-ligand system may be useful for the extraction and separation of individual lanthanides and also for the separation of lanthanides as a group from other metal ions.


Related Compounds

Related Articles:

Influence of sub-inhibitory antibiotics and flow condition on Staphylococcus aureus ATCC 6538 biofilm development and biofilm growth rate: BioTimer assay as a study model.

2014-11-01

[J. Antibiot. 67(11) , 763-9, (2014)]

The effects of a TGR5 agonist and a dipeptidyl peptidase IV inhibitor on dextran sulfate sodium-induced colitis in mice.

2015-03-01

[J. Gastroenterol. Hepatol. 30 Suppl 1 , 60-5, (2015)]

Synthesis and structures of tridentate ketoiminate zinc complexes bearing trifluoromethyl substituents that act as L-lactide ring opening polymerization initiators.

2013-04-21

[Dalton Trans. 42(15) , 5573-86, (2013)]

4,7-Dichloro benzothien-2-yl sulfonylaminomethyl boronic acid: first boronic acid-derived beta-lactamase inhibitor with class A, C, and D activity.

2010-04-15

[Bioorg. Med. Chem. Lett. 20 , 2622-4, (2010)]

First bite syndrome: Our experience with intraparotid injections with botulinum toxin type A.

2016-01-01

[Laryngoscope 126 , 104-7, (2016)]

More Articles...